Inactivation of rabbit red blood cell hexokinase activity promoted in vitro by an oxygen-radical-generating system.
Rabbit red blood cell hexokinase (EC 2.7.1.1) has been shown to be inactivated in vitro by incubating intact erythrocytes in the presence of an oxygen-radical-generating system represented by ascorbate and iron. It was interesting to note that among the glycolytic enzymes, only hexokinase was found to be susceptible to the action of oxygen radicals, suggesting that the loss of activity of this enzyme may be one of the first signals of cellular damage in rabbit red blood cells. This statement is supported by the fact that, under the experimental conditions used, we did not observe any significant plasma membrane lipid peroxidation nor intracellular proteolysis. Furthermore, mature erythrocytes are unable to synthesize hexokinase as well as other proteins de novo; therefore, the inactivation of this enzyme, which is both the first and one of the rate-limiting enzymes of the glycolytic pathway, could play an important role in determining metabolic impairment of red blood cells, with possible physiological implications. We also investigated the effect of various radical scavengers and antioxidants (glucose, vitamin E, dithiothreitol, flavonoids) which are able to influence the inactivation of hexokinase activity to different extents. Finally, under the experimental conditions used (90 min of incubation at 37 degrees C), we did not observe any difference in the hemolysis of rabbit red blood cells incubated in the presence or absence of ascorbate and iron (hemolysis was about 1% after 90 min of incubation), suggesting that the system used was able to furnish information about the cellular damage produced by oxygen radicals without provoking cell lysis.
Stocchi
V
V
Istituto di Chimica Biologica Giorgio Fornaini, Università di Urbino, Italy.
Biagiarelli
B
B
Fiorani
M
M
Palma
F
F
Piccoli
G
G
Cucchiarini
L
L
Dachà
M
M
D000251:Adenosine Triphosphatases / Q000097:blood; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D010450:Endopeptidases / Q000097:blood; D004910:Erythrocyte Membrane / Q000201:enzymology; D004912:Erythrocytes / Q000201:enzymology*; D016166:Free Radical Scavengers; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione / Q000378:metabolism; D006593:Hexokinase / Q000037:antagonists & inhibitors* / Q000097:blood; D007501:Iron / Q000494:pharmacology; D015227:Lipid Peroxidation; D010084:Oxidation-Reduction; D011817:Rabbits; D017382:Reactive Oxygen Species / Q000494:pharmacology*; D014810:Vitamin E / Q000494:pharmacology
D000975:Antioxidants; D016166:Free Radical Scavengers; D017382:Reactive Oxygen Species; D014810:Vitamin E; D007501:Iron; D006593:Hexokinase; D010450:Endopeptidases; D000251:Adenosine Triphosphatases; D005978:Glutathione; D005947:Glucose; D001205:Ascorbic Acid; D004229:Dithiothreitol